Meet The Top Attys Battling McKinsey In New Opioid MDL

Law360 (August 20, 2021, 8:04 PM EDT) — In the second multidistrict litigation over the opioid crisis, McKinsey & Co. will lock horns with veterans of the first opioid MDL as well as a BigLaw alumnus who launched a firm devoted to his pioneering litigation against the consulting powerhouse.

U.S. District Judge Charles R. Breyer, who is presiding over the newly formed MDL in San Francisco, in recent days plucked 10 lawyers from a bushel of 26 applicants to form a plaintiffs’ steering committee for cases accusing McKinsey of masterminding drug marketing tactics that ignited a firestorm of opioid addiction.

The 10 chosen ones collectively boast more than 150…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Comments are closed.